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1. Introduction 
The sensing of the status of energy stores and the quality and quantity of the consumed food 
by the central nervous system (CNS) plays crucial role in the regulation of energy 
homeostasis. This regulation is guided by the communication between the peripheral organs 
and the brain.  
The two main routes of this communication are the peripheral nerves, primarily the vagus 
nerve, and the blood circulation. The vagus nerve mediates the effects of some gastrointestinal 
hormones and the information from chemo- and mechanosensors of the gastrointestinal tract 
towards the nucleus tractus solitarii in the brainstem. While the primary central target of the 
blood-transported signals, like nutrients, such as glucose, amino and fatty acids, nutrition-
dependent gastrointestinal hormones, like glucagon-like peptide 1 (GLP-1), peptide YY 
(PYY), cholecysokinin (CCK) and ghrelin or adiposity signals, like the white adipose tissue-
derived leptin and the pancreatic insulin is the hypothalamic arcuate nucleus (ARC).  
The ARC is located in the vicinity of the blood-brain-barrier-free median eminence (ME). 
This way, blood-derived hormones and metabolites can easily reach the neurons in this brain 
area. The ARC contains at least two feeding-related neuronal populations: the 
proopiomelanocortin (POMC) and cocaine- and amphetamine-regulated transcript (CART) 
synthesizing anorexigenic neurons in the lateral part of the ARC and the neuropeptide Y 
(NPY), agouti-related peptide (AgRP) and gamma-aminobutyric acid (GABA) producing 
orexigenic cell population in the ventromedial part of the ARC. The NPY/AGRP and the 
POMC/CART neurons of the ARC transmit the peripheral information toward the so-called 
second-order neurons. These neurons express melanocortin and NPY receptors.  
As both the NPY/AgRP and the POMC/CART neurons have widespread projections, the 
second order neurons are also found in many brain areas including the hypothalamic 
paraventricular nucleus (PVN), the hypothalamic dorsomedial nucleus (DMN) and cell groups 
of the lateral hypothalamus (LH) which are also involved in the regulation of energy 
homeostasis. The role of the orexigenic and anorexigenic populations of the ARC and their 
intra- and extra-hypothalamic connections in the regulation of energy homeostasis has been 
widely investigated; however, the role of glial cell types of the brain in these processes is far 
less understood. 
Tanycytes are specialized glial cells that line the floor and the ventrolateral walls of the third 
ventricle between the rostral and caudal limits of the hypothalamic ME. Earlier, tanycytes 
were simply considered as supporting and barrier forming cells, but during the last years 
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number of data was published demonstrating that tanycytes can actively regulate neuronal 
functions in the hypothalamus. Indeed, by expressing several elements of the glucosensing 
mechanism, tanycytes are involved in the regulation of glucose homeostasis and represent a 
leptin- and amino acid-sensitive niche. Tanycytes also act as precursor cells producing ARC 
neurons even in adult animals. As neurons, located in ARC are involved in the regulation of 
energy homeostasis, it is likely, that tanycytes have the ability to renew neuronal populations 
involved in the regulation of energy metabolism. 
Another glial cell type of the brain is represented by the microglia. Microglia performs the 
task like the macrophage cells and monocytes in the peripheral tissues, namely, the main role 
of the microglia is to scavenge all the foreign materials and the damaged cells and to secrete 
immune factors. Under physiological conditions, glial cells support the normal energy 
homeostasis of the ARC neurons, however, certain conditions, like high-fat diet (HFD) can 
lead to misregulation of this glia-neuron cooperation. Previous investigations have shown 
that, chronic HFD is linked to immune cell-mediated inflammatory responses initiating 
insulin resistance in several organs like liver, skeletal muscle and adipose tissue. Besides 
peripheral consequences of the HFD it was shown, that the hypothalamus is also affected by 
diet-induced inflammation, moreover, the central inflammatory response represents a more 
rapid process that might be initiated by the activation of microglia. This glial activation is 
claimed to be important in the development of diet induced obesity and the associated 
metabolic changes.  
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2. Aims 
The neuronal networks involved in the central regulation of energy homeostasis were 
intensely studied during the last decades. Recently, however, more and more data accumulate 
suggesting that glial cells are also involved in the regulatory apparatus of energy homeostasis. 
Tanycytes, a special glial cell type of the hypothalamus represent a glucose- and leptin-
sensitive, diet-responsive neurogenic niche and play an active role in the transportation of 
metabolic signals to the hypothalamic neurons involved in the regulation of food intake and 
energy balance. Microglia, the resident macrophage cells of the brain are also involved in the 
regulation of energy homeostasis, like via the HFD-related inflammatory processes. However, 
the exact role of these glial cell types in the central regulation of energy homeostasis is still 
unclear.  
To better understand how tanycytes and microglia regulate energy metabolism- and feeding-
related mechanisms, the aim of my PhD work was to investigate the communication and the 
POMC gene expression of tanycytes and the importance of microglia in the development of 
short-term HFD-induced metabolic changes. 
In order to achieve this, our specific aims were: 
1. To investigate the localization of Connexin 43 (Cx43) gap junctions and hemichannels 
in tanycytes. 
2. To characterize the POMC expression in tanycytes 
3. To determine the importance of the microglia in the mediation of the HFD-induced 
metabolic changes. 
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3. Methods 
3.1. Experimental animals and anesthesia 
The experiments were carried out on laboratory mice or rats. The animals used in each 
experiment are listed in Table 1. The animals were housed under standard environmental 
conditions (lights on between 06.00 and 18.00 h, temperature 22 ± 1 °C, chow and water ad 
libitum). All experimental protocols were reviewed and approved by the Animal Welfare 
Committee at the Institute of Experimental Medicine of the Hungarian Academy of Sciences. 
The anesthesia of the animals was performed either by using intraperitoneal injection of a 
mixture of ketamine and xylazine (50 and 10 mg/kg body weight, respectively) or by 
inhalation of isoflurane. 
Table 1: The strain, source, sex, age and body weight of the experimental animals by projects 
The strain, source 
source, sex, age and body weight 
Experiment Species Strain Source Sex Age Body 
weight (g) 
The localization of Cx43 gap junctions and hemichannels in tanycytes 
 mouse CD1 Charles 
River Lab 
M 8 weeks 30-35 
Characterization of POMC expression in tanycytes 
ISH,  
fluorescent IHC 
rat Sprague-
Dawley 
Taconic 
Farms 
M/F 8-15 weeks 
or 31 days 
240-440 or 
60-95 
Immuno-electron 
microscopy 
rat Wistar ToxiCoop M 8 weeks 250-275 
Importance of microglia in the development of HFD induced metabolic changes 
 mouse C57Bl/6J Charles 
River Lab 
M 8 weeks 20-25 
3.2. Transcardial perfusion with fixative 
Animals processed for immunocytochemistry were deeply anesthetized and transcardially 
perfused with 10 ml (mice) or 50 ml (rats) 0.01 M phosphate buffered saline (PBS, pH 7.4) 
followed by fixative listed in Table 2.  
Table 2: The fixative used in the projects 
Immunohistological project Fixative 
Cx43 immunofluorescence 4% PFA in sodium-acetate buffer (pH 6) followed by 4% 
PFA in Borax buffer (pH 8.5) 
Iba1 immunohistochemistry 4% PFA (pH7.4) 
POMC, ACTH, α-MSH immunofluorescence 4% PFA (pH7.4) 
POMC immune-electron microscopy 4% acrolein 2% PFA (pH 7.4) 
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3.3. Tissue preparation for light microscopic investigations 
For light microscopy, the brains were postfixed for 2 hours in 4% paraformaldehyde (PFA) 
and incubated in 30% sucrose in 0.01 M PBS overnight. Brains were frozen on dry ice and 30 
µm thick coronal sections were cut on a freezing microtome. After treatment in 0.5% Triton 
X-100 and 0.5% H2O2 in 0.01 M PBS for 20 min, the sections were placed in 2% normal 
horse serum (NHS) in PBS for 20 min. The used antibodies are listed in Table 3.  
3.4. Tissue preparation for electron microscopic investigations 
For electron microscopy, the brains were postfixed in 4% PFA for 24 h at 4°C, then serial 25 
µm thick coronal sections of the hypothalamus were cut on a vibratome. When the fixative 
contained acrolein, the sections were incubated in 1% sodium-borohydride dissolved in 0.1 M 
phosphate buffer (PB, pH 7.4) for 30 min. In all cases, the sections were treated in 0.5% H2O2 
in PBS for 15 min. Sections were cryoprotected and were frozen over liquid nitrogen and 
thawed quickly three times to improve antibody penetration. To reduce non-specific antibody 
binding, the sections were incubated in 2% NHS in PBS for 10 min. The used antibodies are 
listed in Table 3.  
3.5. Embedding for electron microscopic studies 
The immunolabeled sections were osmicated using 1% osmium tetroxide in 0.1 M PB for 1 h. 
The sections were washed in 50 and 70% ethanol, sequentially, and incubated in 2% uranyl-
acetate in 70% ethanol for 30 min. After dehydration the sections were embedded in 
Durcupan ACM epoxy resin on liquid release agent coated slides and polymerized at 60°C for 
48 h. 
3.6. Tissue preparation for in situ hybridization (ISH) 
Rats were anesthetized and decapitated. The brains were removed and frozen on powdered 
dry ice. Coronal, 18 μm thick sections were cut using a cryostat, thaw-mounted on Superfrost 
glass slides as series and air-dried. The sections were stored at -80°C until processed for ISH. 
3.7. Tissue preparation for laser capture microdissection (LCM) 
Animals were deeply anesthetized and transcardially perfused with 30 ml (mice) or 70 ml 
(rats) ice-cold 10% RNAlater solution. The brains were frozen in -40°C 2-methylbutane. 
Coronal, 12 µm thick sections were cut on a cryostat. Sections were mounted on PEN-
membrane slide and counterstained with 0.6% cresyl violet dissolved in 70% ethanol and 
dehydrated with ascending series of ethanol. The slides were dried on a 42°C plate and stored 
at -80°C until LCM. 
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3.8. LCM and RNA isolation 
Tanycyte cell bodies and the area of the ARC were microdissected separately by using Zeiss 
Microbeam Laser Capture Microdissection system. The samples were pressure-catapulted 
with a single laser pulse into 0.5 ml adhesive cap tubes using x10 objective lenses. RNA was 
isolated from the samples by using Arcturus PicoPure RNA Isolation Kit and DNase 
treatment was carried out by using RNase-free DNase set. The quality and the concentration 
of the isolated RNA samples were measured on Agilent 6000 RNA Pico chips with Agilent 
Bioanalyzer using 2100 Expert Samples with RNA integrity number below 5.0 were excluded 
from further studies. 
DETAILED METHODS BY PROJECTS 
3.9. The localization of Cx43 gap junctions and hemichannels in tanycytes 
3.9.1. Loading the tanycytes with Lucifer yellow (LY) via patch pipette 
Coronal 250 µm thick slices of mouse brain containing the ME were cut using a vibratome 
and then the slices were transferred into artificial cerebrospinal fluid (aCSF) at 36°C. After 
cooling down to room temperature, tanycytes were patched in aCSF. The patch pipettes were 
filled 1 mg/ml LY containing intracellular solution. The tanycytes were loaded with LY for 20 
min at -80–85 mV holding potential. Then other tanycytes were loaded with LY in the 
presence of a gap junction inhibitor, carbenoxolone (200 µM), in the extracellular solution. 
All studied slices were then fixed in 4% PFA in 0.1 M PB (pH 7.4) and studied using a Zeiss 
LSM 780 confocal laser scanning microscope.  
3.9.2. Double-labeling immunofluorescence for Cx43 and vimentin 
Animals were transcardially perfused by fixative (3.2) and the tissues were prepared for 
immunohistochemistry (3.3), then Cx43-vimentin double-labeling immunofluorescence was 
carried out (Table 3). The sections were examined with Zeiss LSM 780 confocal laser-
scanning microscope  
3.9.3. Ultrastructural detection of Cx43-immunoreactivity 
Animals were transcardially perfused by fixative (3.2) and tissues were prepared for electron 
microscopic investigations (3.4). Immunohistochemistry for Cx43 was carried out (Table 3). 
After embedding (3.5), 60–70 nm thick ultrasections were cut with Leica Ultracut UCT 
ultramicrotome. The ultrathin sections were mounted onto Formvar-coated single slot grids, 
contrasted with 2% lead citrate and examined with a Jeol-100 C transmission electron 
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microscope. The tanycytes were identified based on their characteristic morphological 
features, while the tanycyte subtypes were distinguished based on their localization. 
3.10. Characterization of the POMC expression in tanycytes 
3.10.1. Radioactive ISH 
Animals were decapitated and tissues were prepared for ISH (3.6). The tissues were 
hybridized with 35S labeled riboprobe synthesized from mouse Pomc cDNA. Following 
stringency washes, sections were dehydrated in ascending series of ethanol, air-dried, and 
dipped into Kodak NTB autoradiography emulsion. The autoradiograms were developed after 
8 days.  
3.10.2. Fluorescent ISH combined with immunofluorescence 
Animals were decapitated and tissues were prepared for ISH (3.6). The sections were 
hybridized with digoxigenin-11-UTP labeled Pomc riboprobe. Following the 
posthybridization procedure, sections were treated with 0.5% Triton X-100/0.5% H2O2 in PBS 
(pH 7.4) for 15 min, rinsed in PBS, immersed in maleate buffer and in 1% blocking reagent 
for nucleic acid hybridization. The used antibodies are listed in Table 3.  
3.10.3. Immunofluorescent detection of POMC, β-endorphin, α-MSH and 
adrenocorticotropic hormone (ACTH) 
Animals were transcardially perfused by fixative (3.2) and the tissues were prepared for 
immunohistochemistry (3.3), then fluorescent double- and triple-labeling 
immunohistochemistry was carried out. The used antibodies are listed in Table 3. 
3.10.4. Ultrastructural detection of POMC-immunoreactivity in tanycytes 
Animals were transcardially perfused by fixative (3.2) and tissues were prepared for electron 
microscopic investigations (3.4). Immunohistochemistry for POMC was carried out (Table 3). 
After embedding (3.5), 60–70 nm thick ultrasections were cut with Leica Ultracut UCT 
ultramicrotome. The ultrathin sections were examined with a Jeol-100 C electron microscope. 
3.10.5. RNA-seq analysis of tanycyte transcriptome 
After preparation of RNA from LCM isolated tanycytes, ovation RNA amplification system 
V2 was used to amplify the RNA and write cDNA. The library generation and the Illumina 
next generation sequencing and the bioinformatic analyses were performed by Eurofins. CPM 
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values for each gene were compared between the tanycyte and ARC samples with Student's t-
test. 
3.11. Importance of microglia in the development of HFD induced metabolic 
changes  
3.11.1. Microglia-ablation and short-term HFD 
After 3 weeks of consumption of low-fat diet chow (LF, with 10% fat) with or without 
PLX5622 (selective microglia depleting compound), the half of the experimental animals was 
switched to HFD (60% fat), while the other half continued consuming the LF for 3 days. 
3.11.2. Indirect calorimetric measurements and body composition analysis 
In order to evaluate the effect of short-term HFD on the metabolism of the PLX-treated and 
control mice, water and food intake and locomotor activity were measured and indirect 
calorimetric measurements including O2 consumption and CO2 production were performed 
with the TSE PhenoMaster System during the three days of the HFD. The metabolic data was 
analyzed with the TSE PhenoMaster software. Before and after the metabolic measurements, 
body composition was analysed by EchoMRI Whole Body Composition Analyzer. 
3.11.3. Iba1 immunocytochemistry 
Animals were transcardially perfused by fixative (3.2) and the tissues were prepared for 
immunohistochemistry (3.3), then Iba1 immunohistochemistry was carried out (Table 3). The 
sections were examined with a Zeiss Axioimager M2 fluorescent microscope. 
3.11.4. Quantitative TaqMan PCR 
After tissue preparation for LCM (3.7) LCM and RNA isolation (3.8), the RNA samples were 
reverse transcribed by using ViLO Superscript III cDNA Reverse Transcription Kit. The 
cDNA product served as a template for preamplification by using Preamp Master Mix Kit. In 
order to verify the microglia ablation in the ARC, the expression of Iba1 and Emr1 and Gapdh 
as housekeeping were determined by qPCR. ViiA 7 real-time PCR platform was used for 
thermal cycles of the qPCR with the usage of Fast-96 well block and comparative CT method. 
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Table 3: Antibodies, reagents, fluorochromes and chromogens used for immunohistochemical studies 
  Detected 
antigen 
Primary antibody Detection 
Double-labeling 
immunofluorescence 
Cx43 Rabbit antiserum against Cx43 
(Invitrogen, 1:400) 
Alexa-488 conjugated donkey anti-
rabbit IgG (Invitrogen, 1:250) 
vimentin Sheep antiserum against vimentin 
(Santa Cruz Biotech, 1:3000) 
Biotinylated donkey anti-sheep IgG 
(Jackson ImmunoResearch, 1:500), 
ABC (Vector Laboratories, 1:1000), 
biotinylated tyramide amplification, 
Alexa-594 conjugated Streptavidin 
(Invitrogen, 1:500) 
Electron microscopic 
investigations 
Cx43 Rabbit antiserum against Cx43 
(Invitrogen, 1:2000) 
Biotinylated donkey anti-rabbit IgG 
(Jackson ImmunoResearch, 1:500), 
ABC (Vector Laboratories, NiDAB 
ISH combined with 
immunofluorescence 
digoxigenin Peroxidase conjugated sheep 
antiserum against Dig (Roche, 
1:100) 
Biotinylated tyramide amplification, 
Alexa Fluor 488-conjugated 
Streptavidin (Life Technologies, 
1:500) 
HuC/HuD Mouse antiserum against HuC/D 
(Life Technologies 2 µg/ml) 
Alexa Fluor 647-conjugated donkey 
anti-mouse IgG  (Jackson,  
vimentin Chicken antiserum against 
vimentin (Millipore, 1:4000) 
Cy3-conjugated donkey anti-chicken 
(Jackson) 
Triple labeling 
immunofluorescence 
POMC Rabbit antiserum against POMC 
(Phoenix Pharma, 1:20000) 
Alexa 488-conjugated donkey anti-
rabbit IgG (Jackson, 1:400) 
HuC/HuD Mouse antiserum against HuC/D 
(Life Technologies 1 µg/ml) 
Cy3-conjugated donkey anti-mouse 
IgG (Jackson, 1:200) 
vimentin Chicken antiserum against 
vimentin (Millipore, 1:20000) 
Alexa 647-conjugated donkey anti-
chicken IgG (Jackson, 1:200) 
Double-labeling 
immunofluorescence 
β-endorphin Rabbit antiserum against β-
endorphin (Phoenix Pharma, 
1:10000) 
Cy3-conjugated donkey anti-rabbit 
IgG (Jackson, 1:200) 
α-MSH Sheep antiserum against α-MSH 
(Millipore, 1:10000) 
Alexa 488-conjugated donkey anti-
sheep IgG (Jackson, 1:200) 
Single-labeling 
immunofluorescence 
ACTH Rabbit antiserum against ACTH 
(Phoenix Pharma, 1:10000) 
Cy3-conjugated donkey anti-rabbit 
IgG, Jackson, 1:200) 
Electron microscopic 
investigations 
POMC Rabbit antiserum against POMC 
(Phoenix Pharma, 1:15000) 
Biotinylated donkey anti-rabbit IgG 
(Jackson, 1:500), ABC, biotinylated 
tyramide amplification, NiDAB, 
Gallyas developer 
Light microscopic 
investigations 
Iba1 Rabbit antiserum against Iba1 
(Wako, 1:2000)  
Biotinylated donkey anti-rabbit IgG 
(Jackson, 1:500), ABC, NiDAB 
  
11 
 
4. Results 
4.1. The localization of Cx43 gap junctions and hemichannels in tanycytes 
4.1.1. Presence of functional gap junctions between tanycytes 
The fluorescent dye LY loaded into a single β-tanycyte via patch pipette was able to spread 
into a larger group of the adjacent tanycytes and labeled both cell bodies and the basal 
processes of these cells. The expansion of the dye was not only apparent by movement 
between adjacent tanycyte cell bodies, but it also transported among contiguous tanycyte end 
feet process. LY also appeared around blood vessels contacted by tanycyte processes. To 
determine whether LY spread through Cx43 gap junctions, the experiment was repeated in the 
presence of the gap junction inhibitor, carbenoxolone. The inhibitor completely prevented the 
spreading of LY and the fluorescent labeling was only present in the patched cell,  
4.1.2. Detection of Cx43-immunoreactivity in tanycytes 
Double-labeling immunocytochemistry for Cx43 and vimentin, the latter a molecular marker 
of glial cells including tanycytes, demonstrated an abundance of Cx43 in tanycytes. The 
highest density of Cx43-immunoreactive puncta was observed in the cell bodies of 
tanycytes, although Cx43 was also present, but in lower density, in -tanycyte cell bodies 
lining the floor of the third ventricle. The location of Cx43-immunoreactivity in tanycyte cell 
bodies appeared to be polarized, as the greatest density concentrated primarily on the 
ventricular surface of tanycytes, but was also present in lower density on the lateral surfaces 
of adjacent tanycyte cell bodies. Cx43-immunoreactivity was also observed in basal processes 
of both - and -tanycytes and particularly apparent in the external zone of the ME and ARC 
where the processes were in close proximity to capillaries. 
4.1.3. Ultrastructural localization of Cx43-immunoreactivity in tanycytes 
Ultrastructural examination of tanycytes demonstrated that Cx43-immunoreactivity was 
confined to the outer cell membranes. In instances where the lateral surface of tanycyte cell 
bodies was adjacent to each other, Cx43-immunoreactivity was present in the contacting 
cytoplasmic membranes of both cells, supporting the existence of gap junctions. As observed 
by confocal microscopy, the ventricular surface of tanycytes, including their protrusions 
projecting into the third ventricle, were densely labeled with silver grains denoting Cx43-
immunoreactivity, particularly in more dorsal portions of the third ventricular wall where both 
tanycytes and ependymal cells are found. Cx43-immunoreactivity was also present in the 
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cytoplasmic membrane of tanycyte end feet processes, terminating on capillaries both in the 
ARC and in the external zone of the ME. In addition, Cx43 was concentrated in cytoplasmic 
membrane of tanycyte end feet processes where the end feet processes were juxtaposed to 
another tanycyte process or to axon varicosities. 
4.2. Characterization of the POMC expression in tanycytes 
4.2.1. Pomc mRNA expression in non-neuronal cells 
By radioactive and fluorescent in situ hybridization on serial coronal sections of rats covering 
the entire rostrocaudal extent of the tanycyte region and ARC, a large variability between 
brains was observed as to the extent and abundance of Pomc expression in tanycytes and 
similar non-neuronal cells of the ME and pituitary stalk. Therefore, we categorized the brains 
according to the Pomc mRNA content of tanycytes: low-, intermediate- or high-level of non-
neuronal Pomc mRNA.  
In brains with low-level of non-neuronal Pomc mRNA, the Pomc signal was largely confined 
to a population of cells in the pituitary stalk and a caudal subset of β- and the most ventral α-
tanycytes. Hybridization signal was also present in several non-neuronal cells in the caudal 
ME. Rostral to Bregma level -3.1 mm, only few β tanycytes and non-neuronal ME cells 
contained hybridization signal. In these brains, the hybridization signal in tanycytes was 
generally much lower than in POMC neurons. In brains with high-level of non-neuronal Pomc 
mRNA, the hybridization signal extended rostro-caudally to virtually the entire β-tanycyte 
population, dorsally to a large portion of α2-tanycytes, and to more non-neuronal cells in the 
ME and pituitary stalk. Pomc mRNA was never observed, however, in the most dorsal 
tanycyte population, the α1-subtype. In these “high-level” brains, the intensity of tanycyte 
hybridization signal approximated that of POMC neurons. In brains with “intermediate-level” 
of non-neuronal Pomc mRNA, the general pattern was similar to “high-level” brains, but the 
intensity of tanycyte hybridization signal remained well below that of POMC neurons, 
particularly in the rostral half of the tanycyte region. 
This variability was observed in both adult males and females, with similar age and body 
weight, which were euthanized together within 2 h of the mid-day period. Among the total 26 
rat brains we analyzed with ISH, 10 brains had low, 5 intermediate and 11 high Pomc mRNA 
levels in tanycytes. Importantly, variability was observed in both young adult rats, between 
ages 8-10 weeks, and in fully adult, 15 week-old rats. 
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To examine whether variability in non-neuronal Pomc mRNA is present before adulthood, 
ISH was performed in adolescent, 31 day old male and female rats. Hybridization pattern in 
all of the 8 young rats was highly similar to that observed in “low-level” adult rats. Moderate 
signal was present in the pituitary stalk, as well as in a portion of β1-, β2-, α2- and in 
tanycytes in mid and caudal levels of the third ventricle and ME. Signal in the rostral half of 
the tanycyte region was occasional and very light. Neuronal Pomc hybridization signal was 
also less intense than in adults. 
4.2.2. Non-neuronal Pomc mRNA-expressing cells are vimentin-positive 
tanycytes 
To ascertain the identity of non-neuronal cells that express Pomc mRNA and to 
unambiguously distinguish them from POMC neurons, we combined fluorescent ISH with 
immunofluorescence for the tanycyte/ependymal marker, vimentin, and the neuronal marker, 
HuC/D. While few POMC neurons were regularly found in the ME and pituitary stalk, 
occasionally even within the β-tanycyte layer, we did not observe Pomc mRNA-expressing 
cells that contained both vimentin and HuC/D. Pomc mRNA-expressing cells in the 
ventricular wall, corresponding to the location of β1-, β2- and α2-tanycytes, always contained 
vimentin. The vast majority of non-neuronal Pomc mRNA-expressing cells that are located 
below the β-tanycyte layer throughout the external zone of the ME also contained vimentin. 
These cells were apparently tanycyte-type cells often with an elongated shape perpendicular 
to the ventricular floor, or with a small, round-shaped cell body with multiple processes. 
Pomc mRNA-expressing cells in the pituitary stalk had round or elongated shape with 
apparent processes and virtually always contained vimentin. Many of these cells were non-
ependymal tanycyte-type cells, while others in the rostral part of the stalk were β-tanycytes 
bordering the third ventricular recess. To easily identify and distinguish these cells from the 
other tanycyte subtypes, we decided to integrate them into the tanycyte nomenclature and 
refer to them as gamma- (γ) tanycytes. 
4.2.3. Variable POMC protein expression in tanycytes of adult mice  
Immunofluorescence using an antibody against the N-terminal portion of POMC yielded the 
same pattern of cellular expression and variability as Pomc ISH experiments. In “low-level” 
brains, POMC was present in tanycytes of the pituitary stalk and a subset of β- and γ-
tanycytes between Bregma levels -3.1 and -3.8 mm. Rostral to this level, POMC was present 
in some β-tanycyte processes and γ-tanycytes in the ME, the number of which varied among 
“low-level” brains. In “high-level” brains, POMC was present in the vast majority of β- and 
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α2-tanycytes, and a large number of γ-tanycytes, essentially mirroring Pomc mRNA 
distribution in “high-level” brains. Of 8 adult male brains, 3 had low, 2 intermediate and 3 
high POMC levels in tanycytes; of 7 female brains, 5 had low, 1 intermediate and 1 high 
POMC levels. 
The varying shapes and morphological characteristics of POMC-positive γ-tanycytes, clearly 
delineated by the POMC immunofluorescent signal, were essentially identical to the original 
descriptions of these cells. Triple immunofluorescence studies confirmed our combined 
ISH/immunofluorescence findings that POMC-positive γ-tanycytes were virtually always 
vimentin positive and comprised separate population from POMC neurons that were 
vimentin-negative but HuC/D-positive. By location, POMC neurons of the ME were found 
exclusively in the internal zone, close to and occasionally within the β-tanycyte-layer. POMC-
positive γ-tanycytes, however, extended from the subependymal zone to the external zone. 
4.2.4. Ultrastructural examination of POMC-immunoreactive cells in the ME 
By electron microscopic examination of the ME, POMC-immunoreactivity was detected in 
cell bodies and processes of β-tanycytes as well as in γ-tanycytes. Gamma-tanycytes in the 
ME had characteristics similar to β-tanycytes, including elongated mitochondria in their 
processes and large lipid drops. Their processes often terminated on capillaries. 
4.2.5. Detection of POMC-derived peptides in tanycytes 
β-endorphin immunofluorescence resulted in highly similar patterns and variability as the 
POMC staining, but labeled substantially fewer tanycytes in the same brains. Namely, in 
“low-level” brains, non-neuronal β-endorphin staining was confined to some γ-tanycytes in 
the pituitary stalk and ME, as well as few β-tanycyte cell bodies and processes. In “high-
level” brains, β-endorphin staining labeled many more β- and γ-tanycytes, as well as α2-
tanycytes and their processes. Immunofluorescence using anti-ACTH serum labeled only 
occasional γ-tanycytes in the ME and the pituitary stalk. Their number was independent on 
whether the brain had low- or high- POMC level in tanycytes; in some brains there were 1-2 
cells in each section, while in others there were no clear ACTH-positive γ-tanycytes. The 
signal in γ-tanycytes was always much lighter than in neurons or axons. In addition, in brains 
with high Pomc levels in tanycytes we noted a very light ACTH-immunoreactivity primarily 
in α2-tanycyte cell bodies. The α-MSH immunoreactivity that was clearly above background 
level was rare in tanycytes. Light signal was observed occasionally in γ-tanycytes in the ME 
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and pituitary stalk, and in a few tanycyte-processes in brains with high-level Pomc in 
tanycytes. 
4.2.6. Expression of POMC-processing enzymes in tanycytes 
The scarce ACTH and α-MSH immunoreactivity in tanycytes suggested that there may be 
little processing of the POMC precursor in these cells. This would be in agreement with 
previous ISH studies that show no positive signal in tanycytes for the prohormone-convertase 
1 and 2 (PC1, PC2) that cleave the POMC precursor to generate ACTH, and further to α-
MSH, respectively. To further examine whether genes involved in POMC-processing are 
expressed in tanycytes, we used RNA-Seq analysis on the transcriptome of rat tanycytes (α1, 
α2, β1, β2) that were isolated by LCM. Expression levels were compared to samples obtained 
by the same method from the adjacent ARC. Expression values for PC1, PC2, 
carboxypeptidase E, peptidylglycine alpha-amidating monooxygenase, and secretogranin V 
(or 7B2) mRNAs were significantly lower in tanycyte samples than in the ARC, in agreement 
with ISH studies that show predominantly neuronal expression patterns for these genes in the 
hypothalamus. PC2 mRNA had the lowest value in tanycytes, 7.4 ± 0.4, which was below the 
cutoff value of 10.0 considered for positive expression. The second lowest expression, PC1 
mRNA with 16.2 ± 0.8, was only slightly above the cutoff value. Pomc mRNA levels were 
similar in the tanycyte sample and the ARC sample (347.2 ± 36.2 in tanycytes vs. 397.2 ± 
37.0 in the ARC). 
4.3. Importance of microglia in the development of HFD induced metabolic changes 
4.3.1. Effect of HFD and microglia ablation on the body composition and 
metabolic parameters  
After 3 weeks of PLX pretreatment, the experimental animals were divided into four groups: 
LF, HFD, LF+PLX and HFD+PLX consuming the special diet for 3 days.  
At the start of the special diet, there was no significant difference in the body composition of 
the animal groups. During the three days of diet, the change of the lean body mass was 
influenced by both the diet (P=0.001) and the PLX treatment (P=0.025), but there was no 
interaction between the two factors (P=0.241) by factorial ANOVA. The PLX treatment 
caused significant decrease (P=0.02) of the lean body mass of the LF mice (-0.078 ± 0.154 g) 
compared to the elevation of the lean body mass of mice on LF without PLX (0.616 ± 0.239). 
Moreover, significant difference was found between the lean body mass change of the 
LF+PLX and HFD+PLX animals (-0.078 ± 0.154 g vs. 0.883 ± 0.134 g; P=0.004). The change 
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of the total water content and body weight of the mice was influenced only by the diet 
(P=0.002 and 0.003 by factorial ANOVA, respectively), however, it was independent of the 
PLX treatment (P=0.157 and 0.307 by factorial ANOVA respectively). The total water 
content of the HFD+PLX mice had higher increase than that in the LF+PLX mice (0.821 ± 
0.120 vs. -0.109 g ± 0.113 g; P=0.008). Similarly, the HFD+PLX mice had significantly 
higher body weight change than the LF+PLX mice (1.819 ± 0.267 vs.0.436 ± 0.240 g; 
P=0.03). HFD had a tendency to increase the change of the water content and body weight in 
animals without PLX treatment, but this change did not reach the level of significance. 
The total activity of mice was influenced by both the diet (P=0.00048) and the PLX treatment 
(P=0.0004), but there was no interaction between the two factors (P=0.948) by factorial 
ANOVA. During the 3 days of the diet, the mice of the HFD groups had markedly increased 
activity compared to the LF groups. The average total activity of the LF vs. HFD mice was 
2405.98 ± 234.68 vs. 3170.24 ± 552.18 beambreaks/h (P=0.013), while the total locomotor 
activity of the LF+PLX vs. HFD+PLX was 1432.23 ± 244.57 vs. 2246.73 ± 567.09 
beambreaks/hour (P=0.01). The PLX treatment significantly decreased the locomotor activity 
both in LF+PLX and HFD+PLX groups compared to groups without PLX. The average total 
activity of LF vs. LF+PLX mice was 2405.98 ± 234.68 vs. 1432.23 ± 244.57 beambreaks/hour 
(P=0.007), while the average total activity of the HFD vs. HFD+PLX was 3170.24 ± 552.18 
vs. 2246.73 ± 567.09 (P=0.009). The difference between LF and LF+PLX groups was 
significant both in the daylight period and at night, with 1652.92 ± 257.72 vs. 914.79 ± 161.74 
(P=0.02) and 3136.05 ± 267.14 vs. 1949.66 ± 347.06 beambreaks/hour, respectively, (P=0.02). 
However, the difference between HFD and HFD+PLX was only significant at night (4027.00 
± 435.52 vs. 2668.54 ± 662.20 beambreaks/hour, P=0.009). The HFD significantly increased 
the activity of the HFD+PLX mice compared to LF+PLX mice in the daylight period 
(P=0.01), while significantly increased the activity of HFD mice compared to LF mice 
(P=0.047) at night. Similar differences between mice on PLX-free and PLX-containing chow 
groups were found when the ambulatory and fine activity components of the total locomotor 
activity were analyzed.  
The food intake of the HFD group had a tendency to increase during the first day compared to 
LF group (P=0.06), however, this difference did not reach the level of significance and 
seemed to disappear in later time points. The cumulative food intake of HFD treated mice was 
above the consumption of the LF mice independently of the presence or absence of microglia 
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until the second day of the experiment; however, at the end of the experiment, the cumulative 
food intake of all four groups was similar. As the energy content of the LF chow was 3.85 
Kcal/g and the HFD chow was 5.24 Kcal/g, the HFD groups consumed significantly more 
calories compared to the calorie consumption of LF groups (P=0.0000 by factorial ANOVA). 
This was not influenced by the PLX treatment (P=0.637) and there was no interaction 
between the two factors (P=0.567) by factorial ANOVA. The cumulative food intake in Kcal 
of the HFD animals were significantly higher compared to LF animals (LF vs. HFD P<0.01 
and LF+PLX vs. HFD+PLX P<0.05). 
The energy expenditure of the mice was normalized to the lean body mass of each animal. 
The average total energy expenditure of mice was influenced by the diet (P=0.0003), but not 
by the PLX treatment (P=0.162) and no interaction between the two factors was observed 
(P=0.917). There was no difference among the nighttime energy expenditure of the groups 
(P=0.066 and P=0.073). The daytime and the whole day energy expenditure were, however, 
significantly influenced by the diet. During daytime, the HFD significantly increased the 
energy expenditure (P=0.0002) that was not influenced by the PLX-treatment (P=0.162) with 
no interaction between the two factors (P=0.647) by factorial ANOVA. Similar differences 
were observed in the whole day energy expenditure data. The average energy expenditure of 
LF vs. HFD mice was 23.15 ± 1.51 vs. 25.15 ± 0.37 Kcal/kg lean body mass/hour (P=0.02), 
while of LF+PLX vs. HFD+PLX animals were 22.34 ± 0.63 vs. 24.25 ± 0.33 Kcal/kg lean 
body mass/hour (P=0.03). 
As resting energy metabolism cannot be measured, it was estimated from the energy 
expenditure of the time points when the animal eats less than 0.1 g and moves less than 1% of 
the maximum ambulatory value in the preceding 30 minutes. Similarly to energy expenditure 
data, the calculated values were normalized to the lean body mass of the mice. The HFD had 
significant effect on the resting energy expenditure (P=0.0000), while PLX treatment did not 
influence it (P=0.903). The two factor had no interaction (P=0.934) by factorial ANOVA. The 
high-fat content of the diet caused significant increase in the resting metabolism in both PLX 
and PLX-free mice during the daylight, at night and in their average values. The average 
resting metabolism of LF vs. HFD mice was 19.56 ± 1.07 vs. 22.08 ± 0.51 Kcal/kg lean body 
mass/hour (P=0.0001) and the resting metabolism of LF+PLX vs. HFD+PLX mice was 19.46 
± 0.65 vs. 22.30 ± 0.43 Kcal/kg lean body mass/hour (P=0.0001). 
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The respiratory exchange ratio (RER) is a ratio calculated from volume of the produced CO2 
and the consumed O2, which gives further information about the substrate utilization of the 
animals. The diet has significant effect on the RER of the animals, however, the PLX 
treatment had not (P=0.0000 and P=0.872, respectively) and there was no interaction between 
the two factors (P=0.410) by factorial ANOVA. The RER of the HFD-consuming mice was 
significantly higher compared to LF-consuming groups during the 3 days of the experiment. 
The greatest differences were observed during the nighttime periods, when the RER of LF vs. 
HFD mice was 0.99 ± 0.02 vs. 0.79 ± 0.02 (P=0.0001), while the RER of LF+PLX vs. 
HFD+PLX mice was 0.99 ± 0.02 vs. 0.81 ± 0.01 (P=0.0001). This significance was present in 
the average values as well, when both night and daylight data was taken into consideration. 
The average RER of LF vs. HFD mice was 0.93 ± 0.01 vs. 0.77 ± 0.01 and the average RER 
of LF+PLX vs. HFD+PLX mice was 0.92 ± 0.01 vs. 0.79 ± 0.01. As the HFD groups’ fat 
consumption was far above the LF groups’, not surprisingly their fatty acid oxidation was 
significantly higher, as well (P=0.00001), however, the PLX-treatment did not affect the fatty 
acid oxidation of the mice (P=0.353) during the experiment and there was no interaction 
between the two factors (P=0.167) by factorial ANOVA. The average fatty acid oxidation of 
the HFD animals was almost four times higher, than in the LF animals: in the LF vs. HFD 
mice 0.07 ± 0.01 vs. 0.33 ± 0.01 Kcal/hour and in the LF+PLX vs. HFD+PLX mice 0.08 ± 
0.01 vs. 0.29 ± 0.01 Kcal/hour. 
4.3.2. Verification of the microglia-ablation by Iba1 immunohistochemistry and 
PCR 
The microglia ablation of the PLX pretreated mice was effective, independently from the fat 
content of the consumed food according to the microglial marker Iba1 immunoreactivity. The 
PLX treatment markedly decreased the expression of microglial marker Emr1 and Iba1 in the 
ARC independently of the fat content of the diet. The Emr1 expression level of the PLX-
treated animals decreased to approximately 20% of the LF group (0.209 ± 0.04; P=0.0001 and 
0.223 ± 0.08; P=0.0003; in the LF+PLX and HFD+PLX mice, respectively), while Iba1 
expression fell to 10% of the LF group (0.114 ± 0.01; P=0.0001 and 0.152 ± 0.06; P=0.0002, 
in the LF+PLX and HFD+PLX mice, respectively). 
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5. Conclusions 
Our data indicate that tanycytes are interconnected with each other via functional, Cx43-
containing gap junctions, ensuring an effective communication among these cells. The 
presence of Cx43 immunoreactivity on the ventricular surface of tanycytes and on end feet 
processes terminating on capillaries or axon terminals further suggest that there could be an 
active transport of small molecules between tanycytes and different compartments of 
extracellular space through Cx43-containing hemichannels. These findings indicate that 
tanycytes have far more complicated functions than simply serving as barrier cells, and 
support their importance in neuroendocrine regulation by monitoring the extracellular 
environment in the ME-ARC region.  
The present study also reveals a novel, unique type of POMC expression in tanycytes in the 
adult rat hypothalamus and pituitary stalk. Depending on the potential target cells of tanycyte-
derived POMC, we suggest three potential roles for POMC in tanycytes. One is regulating the 
release of hypophysiotropic hormones via acting on hypophysiotropic axons in the ME. A 
second possible function is that tanycyte-derived POMC, acting in a paracrine/autocrine 
manner, may be involved in the proliferative/neurogenic functions of tanycytes themselves. 
Lastly, N-terminal POMC peptides secreted by tanycytes into the portal capillaries of the ME 
may regulate pituitary functions. However, future studies will be necessary to investigate the 
cause of variability, the exact nature of POMC-processing, the functional significance, and the 
potential existence of tanycyte POMC expression in other species. 
The effectiveness of microglia ablation via consuming PLX-containing chow was supported 
by immunocytochemistry and PCR data, however, our work suggest, that the loss of microglia 
does not influence the majority of the metabolic parameters of the mice during the short-term 
HFD. However, even the short time HFD causes marked metabolic changes in mice, 
including change of energy expenditure, RER and fat oxidation and also the elimination of 
diurnal-nocturnal changes of the metabolic parameters observed in control animals. As the 
presence of ARC inflammatory process was not clearly justified, further experiments are 
needed to evaluate the role of tanycytes in this process.  
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